Huons announced on the 29th that it has decided to expand the free support of transmitters for the continuous glucose monitor (CGM) 'Dexcom G6' for diabetes patients. The transmitter is a device that ...
The Non-Insured Health Benefits (NIHB) program establishes exemplary coverage for Dexcom’s real-time continuous glucose monitoring system – bringing game-changing technology to more First Nations and ...
VANCOUVER, Feb. 22, 2019 /CNW/ - Dexcom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), today announced that the company has received Health Canada approval for its next ...
DexCom, Inc. DXCM recently announced the first-ever registry committed toward keeping a track on the outcomes of patients and healthcare professionals using Continuous Glucose Monitoring (CGM) in ...
Dexcom G6 was the first Continuous Glucose Monitoring (CGM) System to be officially listed by the NIHB Drug Benefit program. BURNABY, British Columbia — Dexcom, Inc. (NASDAQ: DXCM), the global leader ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results